Merck Congratulates Awardees of 2015 Nobel Prize in Physiology or Medicine for Discovery Leading to River Blindness Treatment
Dateline City:
KENILWORTH, N.J.
Co-recipient Dr. William C. Campbell Conducted his Nobel Prize-winning Work at Merck Research Laboratories
KENILWORTH, N.J.--(BUSINESS WIRE)--Merck (NYSE:MRK), known as MSD outside the United States and Canada,
proudly congratulates William C. Campbell, a retired scientist from
Merck Research Laboratories, who was jointly named the 2015 Nobel Prize
winner in Physiology or Medicine with Satoshi Omura for the discovery of
avermectin, which led to Merck’s development of Mectizan (ivermectin), a
treatment for river blindness (also known as onchocerciasis) in Africa,
Latin America and Yemen.
Language:
English
Contact:
MerckMedia:Lainie Keller, 908-236-5036orClaire Gillespie, 267-305-0932orInvestors:Terri Loxam, 908-740-1986orJustin Holko, 908-740-1879
Ticker Slug:
Ticker: MRK Exchange: NYSE
read more
Source: Merck.com - Corporate News - Category: Pharmaceuticals Tags: Corporate News Corporate Responsibility News Latest News Source Type: news
More News: African Health | Blindness | Merck | Middle East Health | Opthalmology | Pharmaceuticals | Physiology | River Blindness | Yemen Health